CDC Changes Recommendation for HPV Vaccine for Children
The Advisory Committee on Immunization Practices has changed its recommendation for the human papilloma virus from three doses to two doses of the vaccine prior to age 15.
Ebola Symptoms Absent in Some Infected Persons
A recent study shows that people can be infected with the Ebola virus and not show any symptoms.
HHS Final Rule Protects Research Participants and Modernizes Oversight
The U.S. Department of Health and Human Services, along with 15 other agencies, finalized a rule whose provisions safeguard individuals who participate in research, most of which will go into effect in 2018.
21st Century Cures Act Modifies Medicare Payments for Services
Congress passed the 21st Century Cures Act, which reforms the current standards and appropriations for biomedical research and provides five years of funding for the National Institutes of Health and the U.S. Food and Drug Administration.
Sunlight Produces Faster T Cells to Boost Immunity
Researchers have found that sunlight’s rays speed up helper and killer T cells in the skin.
Scientists Develop Vaccine to Block Opioid Drugs’ Effects
A new vaccine that blocks the pain-numbing effects of the drugs oxycodone and hydrocodone has shown success in animal models.
Scientists Discover Post-Exposure Treatment with Horse Antibodies Is Effective for Ebola
Researchers in Melbourne have developed an effective, rapid and economical treatment for Ebola using antibodies from horses.
No Link Between Flu or Flu Vaccine and Autism, Study Finds
A new study shows that babies of pregnant women who get the flu or who are vaccinated against the flu do not have an increased risk for Autism Spectrum Disorder.
AMA Joins with Other Organizations to Reform Prior-Authorization Requirements
The American Medical Association and a coalition of 16 other organizations representing physicians, medical groups, hospitals, pharmacists and patients have devised a set of 21 principles to guide reform of utilization management programs.
Infusion of BPX-501 T Cells Renders Haplo-HSCT a First-Line Option for Children with PI
A Phase I/II study indicates that haplo identical hematopoietic stem cell transplantation (haplo-HSCT), after depletion of α/β T cells and B cells followed by adoptive infusion of donorBPX-501 cells, is an effective alternative for children with primary immunodeficiency disease (PI) in need of an urgent allograft or lacking a suitable human leukocyte antigen (HLA)-matched donor.
